Abstract
VIP is a peptide synthesised in the pituitary gland and is involved in the stimulation of prolactin secretion. However, to date it has not been determined whether VIP is able to regulate the proliferation of pituitary prolactin-producing cells, like other factors involved in the regulation of prolactin such as estradiol or dopamine. The aim of the present study was to address whether VIP is involved in regulating the proliferation of pituitary prolactin-secreting cells. Thus, we performed an in vitro study on monolayer cultures of rat pituitary cells, neutralising the possible paracrine effect of VIP by immunoblockade of the peptide and later determining the degree of proliferation of prolactin-secreting cells. The effects of immunoblockade were validated by determining the levels of VIP in the culture media, which were decreased (P<0.01), and modifications in the patterns of the immunohistochemical reaction to prolactin-positive cells. Immunoblockade of VIP decreased the proliferation of pituitary prolactin-positive cells at all antibody concentrations analysed, mainly between 3 and 12 h (P<0.01). Moreover, immunoblockade decreased the sizes of the cellular and nuclear areas, except at 1 h, at which point it only decreased the nuclear area of prolactin-positive cells. The results obtained suggest that—in the same way as it regulates the secretion of the hormone—VIP could be involved in regulating the proliferation of prolactin cells, like estradiol or dopamine.
Similar content being viewed by others
References
Arnaout MA, Garthwaite TL, Martinson DR, Hagen TC (1986) Vasoactive intestinal polypeptide is synthesized in anterior pituitary tissue. Endocrinology 119:2052–2057
Asano K, Kubo O, Tajika Y, Huang MC, Takakura K (1996) The relationship between cell proliferation activity and secretory activity in pituitary adenoma, a review of 63 cases. No To Shinkei 48:543–549
Banerjee SK, De A, Sarkar DK (1994) Colocalization of prolactin and proliferating cell nuclear antigen in the anterior pituitary during estrogen-induced pituitary tumours. Cancer Lett 87:139–144
Beauvillain JC, Mazzuca M, Dubois MP (1977) The prolactin and growth hormone producing cells of the guinea pig pituitary. Cell Tissue Res 184:343–358
Berkvens JM, Van Nesselrooy JHJ, Kroes R (1980) Spontaneous tumors in the pituitary gland of old Wistar rats. A morphological and immunocytochemical study. J Pathol 130:179–191
Byrne JM, Jones PM, Hill SF, Bennet WM, Gathei MA, Bloom SR (1992) Expression of messenger ribonucleic acids encoding neuropeptide-Y, substance-P, and vasoactive intestinal polypetide in human pituitary. J Clin Endocrinol Metab 75:983–987
Carbajo E, Montegi M, Watanabe YG (1989) Cell proliferation in the anterior pituitary on mice during growth. Biomed Res 10:275–281
Carbajo-Pérez E, Watanabe YG (1990) Cellular proliferation in the anterior pituitary of the rat during the postnatal period. Cell Tissue Res 261:333–338
Carretero J, Sánchez F, Blanco E, Riesco JM, Sánchez-Franco F, Vázquez R (1989). Morphofunctional study of mammotropic cells following intraventricular administration of met-enkephalin. Anat Embryol 179:243–250
Carretero J, Sánchez F, Blanco E, Riesco JM, González R, Vázquez R (1991) Estrogenic modulation of met-enkephalin-induced prolactin secretion in rats. Anat Embryol 183:455–459
Carretero J, Sánchez F, Rubio M, Lorenzo MJ, Francos M, Cacicedo L, Sánchez-Franco F, Vázquez R (1992) Immunocytochemical evidence of hypothalamic regulation of adenopituitary VIP in the male rat. Neuropeptides 23:239–243
Carretero J, Sánchez F, Rubio M, Francos CM, Blanco J, Vázquez R (1994) In vitro and in vivo evidence for direct dopaminergic inhibition of VIP-immunoreactive pituitary cells. Neuropeptides 27:1–6
Carretero J, Rubio M, Sánchez F, Vázquez RJ, Santos M, Blanco E, Vázquez R (1995a). In vitro morphometric and proliferative variations in VIP-immunoreactive pituitary cells induced by estradiol. Neuroendocrinology 62:277–282
Carretero J, Rubio M, Navarro N, Prieto P, Vázquez RJ, Sánchez F, Vázquez R (1995b) In vitro modifications in the proliferation rate of prolactin cells are accompanied by nuclear morphometric variations. Histol Histopathol 10:135–139
Carretero J, Vázquez RJ, Santos M, Cacicedo L, Rubio M, Sánchez-Franco F, Vázquez R (1996) Dopamine inhibits in vitro release of VIP and proliferation of VIP-immunoreactive pituitary cells. Neuropeptides 30:81–86
Carretero J, Rubio M, Vázquez-Perfecto RJ, Sánchez F, Torres JL, Pérez RM, Vázquez R (1997a) Decreases in the size and proliferation rate of VIP-immunoreactive cells induced in vitro by testosterone are associated with decreases in VIP release. Neuroendocrinology 65:173–178
Carretero J, Rubio M, Sánchez F, Cabo JJ, Vázquez RJ, Santos M, Pérez RM, Vázquez R (1997b) Corticosterone induces hypoactivity of prolactin-immunoreactive cells. Acta Anat 160:15–20
Carretero J, Vázquez RJ, Sánchez F, Rubio M, Santos M, Vázquez G, Martín-Clavijo A, Vázquez R (1998) Inverse effects of estradiol and testosterone on the in vitro proliferation rate of rat VIP-immunoreactive pituitary cells. Eur J Anat 2:101–108
Carretero J, Vázquez G, Blanco E, Rubio M, Santos M, Martín-Clavijo A, Torres JL, Vázquez R (1999a) Immunohistochemical evidence of the presence of aromatase P450 in the rat pituitary gland. Cell Tissue Res 295:419–423
Carretero J, Martín-Clavijo A, Vázquez G, Somalo J, Rubio M, Sánchez F, Hernández E, Montero MC, Torres JL, Vázquez R (1999b) Effects of in vitro immunosupression of interleukin-6 on the proliferation of rat pituitary cells. Eur J Anat 3:137–143
Carrillo AJ, Pool TB, Sharp ZD (1985) Vasoactive intestinal peptide increases prolactin messenger ribonucleic acid content in GH3 cells. Neuroendocrinology 116:202–206
Denef C, Baes M, Schramme C (1986) Paracrine interactions in the anterior pituitary: Role in the regulation of prolactin and growth hormone secretion. In: Ganong WF, Martini L (eds) Frontiers in Neuroendocrinology, vol 9. Raven Press, New York, pp 115–148
Fernandez M, Sanchez-Franco F, Palacios N, Sanchez I, Villuendas G, Cacicedo L (2003) Involvement of vasoactive intestinal peptide on insulin-like growth factor I-induced proliferation of rat pituitary lactotropes in primary culture: evidence for an autocrine and/or paracrine regulatory system. Neuroendocrinology 77:341–352
Hagen TC, Arnaout MA, Scherzer WJ, Martinson DR, Garthwaite TL (1986) Antisera to vasoactive intestinal polypeptide inhibits basal prolactin release from dispersed anterior pituitary cells. Neuroendocrinology 43:641–645
Harbuz MS, Stephanou A, Sarlis N, Lightman SL (1992) The effects of recombinant human interleukin (IL)-1 alpha, IL-1 beta or IL-6 on hypothalamo-pituitary-adrenal axis activation. J Endocrinol 133:349–355
Herbert DC, Ishikawa H, Rennels EG (1979) Evidence for the autoregulation of hormone secretion by prolactin. Endocrinology 104:97–100
Hunt TE (1943) Mitotic activity in the anterior pituitary gland of female rats of different age groups and at different periods of the day. Endocrinology 32:334–339
Kakeya T, Takeuchi S, Takahashi S (2000) Epidermal growth factor, insulin, and estrogen stimulate development of prolactin-secreting cells in cultures of GH3 cells. Cell Tissue Res 299:237–243
Kato Y, Iwasaki Y, Iwasaki J, Abe H, Yanaihara N, Imura H (1978) Prolactin release by vasoactive intestinal polypeptide in rats. Endocrinology 103:554–558
Lam KSL (1991) Vasoactive intestinal peptide in the hypothalamus and pituitary. Neuroendocrinology 53 (suppl):45–51
Lorenzo MJ, Sánchez-Franco F, De los Frailes MT, Reichlin S, Fernández G, Cacicedo L (1989) Synthesis and secretion of vasoactive intestinal peptide by rat fetal cerebral cortical and hypothalamic cells in culture. Endocrinology 125:1983–1990
Nagy G, Mulchahey JJ, Neill JD (1988) Autocrine control of prolactin secretion by vasoactive intestinal peptide. Endocrinology 122:364–366
Nogami H (1984) Fine-structural heterogeneity and morphologic changes in rat pituitary prolactin cells after estrogen and testosterone treatment. Cell Tissue Res 237:195–202
Oishi Y, Okuda M, Takahashi H, Fujii T, Morii S (1993) Cellular proliferation in the pituitary gland of normal adult rats: influences of sex, estrous cycle, and circadian change. Anat Rec 235:111–120
Ortman R, Pérez F Jr (1984) The effect of age, pairing, copulation, and 2-Br-α-ergocryptine in the male Mongolian gerbil on the prolactin cells in the anterior pituitary identified by immunocytochemical and Herlant’s tetrachrome methods. Anat Rec 208:411–420
Peillón F, Le Dafniet M, Pagesy P, Yuan Li J, Benlot C, Brandi AM, Joubert D (1991) Neuropeptides of anterior pituitary origin. Path Res Pract 187:577–580
Pérez RL, Machiavelli GA, Romano MI, Burdman JA (1986) Prolactin release, oestrogens and proliferation of prolactin-secreting cells in the anterior pituitary gland of adult male rats. J Endocrinol 108:399–403
Phelps C (1986) Immunocytochemical analysis of prolactin cells in the adult rat adenopituitary gland: distribution and quantitation relative to sex and strain. Am J Anat 176:233–242
Pomerat GR (1941) Mitotic activity in the pituitary of the white rat following castration. Am J Anat 69:89–121
Reifeld CW, Shin SH, Leather RA (1983) Extensive ultrastructural changes in rat mammotrophs following administration of the dopamine agonist ergocristine reflecting inhibition of prolactin release. Cell Tissue Res 232:249–256
Robberechet W, Denef C (1989) Paracrine interactions in the anterior pituitary. In: Müller EE, MacLeod RM (eds) Neuroendocrine persperctives, vol 6. Springer, Berlin, Heidelberg, New York, pp17–25
Said SI, Porter JC (1979) Vasoactive intestinal polypeptide: release into pituitary portal blood. Life Sci 24:227–230
Segerson TP, Lam KSL, Cacicedo L, Minamitani N, Fink JS, Lechan RM, Reichlin S (1989) Thyroid hormone regulates vasoactive intestinal peptide (VIP) mRNA levels in the rat anterior pituitary gland. Endocrinology 125:2221–2223
Spangelo BL, Judd AM, Isakson PC, MacLeod RM (1989) Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology 125:575–577
Takahashi S, Kawashima S (1982) Age related changes in prolactin cell percentage and serum prolactin levels in intact and neonatally gonadectomized male and female rats. Acta Anat 113:211–217
Torres AI, Aoki A (1985) Subcellular compartmentation of prolactin in rat lactotrophs. J Endocrinol 105:219–225
Torres AI, Aoki A (1987) Release of big and small molecular forms of prolactin: dependence upon dynamic state of the lactotroph. J Endocrinol 114:213–220
Vijayan E, Samson WK, Said SI, McCann SM (1979) Vasoactive intestinal peptide: evidence for a hypothalamic site of action to release growth hormone, luteinizing hormone and prolactin in conscious ovarietcomized rats. Endocrinology 104:53–57
Zhou-Li F, Joly-Pharaboz MO, Bouillard B, Albadalejo E, Nicolas B, Andre J (1991) Multihormonal control of cell proliferation: opposite effects of two stimulators (17β-estradiol and L-triiodothyronine) and one inhibitor (dexamethasone) on F4Z2 pituitary tumor cells. Endocrinology 128:2761–2768
Acknowledgements
This study was supported by the FIS Spanish program N° PI0-21803.
The authors would like to thank Dr. Sánchez-Franco (Service of Endocrinology, INIC Carlos III, Madrid, Spain) for his kind supply of rabbit anti-VIP serum.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carretero, J., Angoso, M., Rubio, M. et al. In vitro immunoblockade of VIP inhibits the proliferation of pituitary prolactin cells. Anat Embryol 211, 11–18 (2006). https://doi.org/10.1007/s00429-005-0058-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00429-005-0058-9